111 related articles for article (PubMed ID: 21488945)
1. Morphologic classification of microvessels in hepatocellular carcinoma is associated with the prognosis after resection.
Chen ZY; Wei W; Guo ZX; Lin JR; Shi M; Guo RP
J Gastroenterol Hepatol; 2011 May; 26(5):866-74. PubMed ID: 21488945
[TBL] [Abstract][Full Text] [Related]
2. Serum and tissue vascular endothelial growth factor predicts prognosis in hepatocellular carcinoma patients after partial liver resection.
Zhong C; Wei W; Su XK; Li HD; Xu FB; Guo RP
Hepatogastroenterology; 2012; 59(113):93-7. PubMed ID: 22251524
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance and implication of neoangiogenesis in hepatocellular carcinoma.
Park JO; Yeh MM
J Gastroenterol Hepatol; 2011 May; 26(5):792-3. PubMed ID: 21488943
[No Abstract] [Full Text] [Related]
4. Overexpression of matrix metalloproteinase-12 (MMP-12) correlates with poor prognosis of hepatocellular carcinoma.
Ng KT; Qi X; Kong KL; Cheung BY; Lo CM; Poon RT; Fan ST; Man K
Eur J Cancer; 2011 Oct; 47(15):2299-305. PubMed ID: 21683576
[TBL] [Abstract][Full Text] [Related]
5. AKR1B10 expression is associated with less aggressive hepatocellular carcinoma: a clinicopathological study of 168 cases.
Schmitz KJ; Sotiropoulos GC; Baba HA; Schmid KW; Müller D; Paul A; Auer T; Gamerith G; Loeffler-Ragg J
Liver Int; 2011 Jul; 31(6):810-6. PubMed ID: 21645211
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of metabolic factors on the prognosis of patients undergoing resection of hepatocellular carcinoma.
Kaibori M; Ishizaki M; Matsui K; Kitade H; Matsui Y; Kwon AH
J Gastroenterol Hepatol; 2011 Mar; 26(3):536-43. PubMed ID: 21332549
[TBL] [Abstract][Full Text] [Related]
7. Lens culinaris agglutinin-reactive fraction of AFP is a useful prognostic biomarker for survival after repeat hepatic resection for HCC.
Matsuda M; Asakawa M; Amemiya H; Fujii H
J Gastroenterol Hepatol; 2011 Apr; 26(4):731-8. PubMed ID: 21155886
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of galectin-1 is associated with poor prognosis in human hepatocellular carcinoma following resection.
Wu H; Chen P; Liao R; Li YW; Yi Y; Wang JX; Sun TW; Zhou J; Shi YH; Yang XR; Jin JJ; Cheng YF; Fan J; Qiu SJ
J Gastroenterol Hepatol; 2012 Aug; 27(8):1312-9. PubMed ID: 22432916
[TBL] [Abstract][Full Text] [Related]
9. Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma.
Zhan DQ; Wei S; Liu C; Liang BY; Ji GB; Chen XP; Xiong M; Huang ZY
J Gastroenterol Hepatol; 2012 Jan; 27(1):173-80. PubMed ID: 21777276
[TBL] [Abstract][Full Text] [Related]
10. Stage progression of small hepatocellular carcinoma after radical therapy: comparisons of radiofrequency ablation and surgery using the Markov model.
Ikeda K; Kobayashi M; Kawamura Y; Imai N; Seko Y; Hirakawa M; Hosaka T; Sezaki H; Akuta N; Saitoh S; Suzuki F; Suzuki Y; Arase Y; Kumada H
Liver Int; 2011 May; 31(5):692-9. PubMed ID: 21457441
[TBL] [Abstract][Full Text] [Related]
11. Osteopontin, a single marker for predicting the prognosis of patients with tumor-node-metastasis stage I hepatocellular carcinoma after surgical resection.
Chen RX; Xia YH; Cui JF; Xue TC; Ye SL
J Gastroenterol Hepatol; 2010 Aug; 25(8):1435-42. PubMed ID: 20659235
[TBL] [Abstract][Full Text] [Related]
12. Continuous improvement of survival outcomes of resection of hepatocellular carcinoma: a 20-year experience.
Fan ST; Mau Lo C; Poon RT; Yeung C; Leung Liu C; Yuen WK; Ming Lam C; Ng KK; Ching Chan S
Ann Surg; 2011 Apr; 253(4):745-58. PubMed ID: 21475015
[TBL] [Abstract][Full Text] [Related]
13. Predictors and patterns of recurrence after resection of hepatocellular carcinoma.
Cha C; Fong Y; Jarnagin WR; Blumgart LH; DeMatteo RP
J Am Coll Surg; 2003 Nov; 197(5):753-8. PubMed ID: 14585409
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of macrophage migration inhibitory factor induces angiogenesis and deteriorates prognosis after radical resection for hepatocellular carcinoma.
Hira E; Ono T; Dhar DK; El-Assal ON; Hishikawa Y; Yamanoi A; Nagasue N
Cancer; 2005 Feb; 103(3):588-98. PubMed ID: 15612021
[TBL] [Abstract][Full Text] [Related]
15. The preoperative positivity for serum hepatitis B e antigen did not affect overall survival after curative resection of hepatitis B virus-related hepatocellular carcinoma.
Choi GH; Kim DH; Choi SB; Kang CM; Kim KS; Choi JS; Lee WJ; Han KH; Chon CY; Kim BR
J Gastroenterol Hepatol; 2009 Mar; 24(3):391-8. PubMed ID: 19032452
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of XPO4 is associated with poor prognosis in hepatocellular carcinoma.
Liang XT; Pan K; Chen MS; Li JJ; Wang H; Zhao JJ; Sun JC; Chen YB; Ma HQ; Wang QJ; Xia JC
J Gastroenterol Hepatol; 2011 Mar; 26(3):544-9. PubMed ID: 21332550
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up of central hepatocellular carcinoma in comparison with non-central hepatocellular carcinoma.
Chang CM; Wei CK; Lee CH; Tseng KC; Lin CW; Yin WY
Hepatogastroenterology; 2012; 59(114):492-5. PubMed ID: 21940385
[TBL] [Abstract][Full Text] [Related]
18. Tumor size as a prognostic factor in resected small hepatocellular carcinoma: a controversy revisited.
Chen YL; Ko CJ; Chien SY; Chen LS; Chen ML; Chi CW; Lai HW
J Gastroenterol Hepatol; 2011 May; 26(5):851-7. PubMed ID: 21129015
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of circumferential cell surface immunoreactivity of glypican-3 in hepatocellular carcinoma.
Yorita K; Takahashi N; Takai H; Kato A; Suzuki M; Ishiguro T; Ohtomo T; Nagaike K; Kondo K; Chijiiwa K; Kataoka H
Liver Int; 2011 Jan; 31(1):120-31. PubMed ID: 20964802
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for long-term prognosis in hepatocellular carcinoma after radiofrequency ablation therapy: the clinical implication of aspartate aminotransferase-platelet ratio index.
Kao WY; Chiou YY; Hung HH; Chou YH; Su CW; Wu JC; Huo TI; Huang YH; Lin HC; Lee SD
Eur J Gastroenterol Hepatol; 2011 Jun; 23(6):528-36. PubMed ID: 21537128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
